On July 22, 2024, Wilson Sonsini partner Dan Koeppen was named to San Diego Business Journal's 2024 “Leaders of Influence in the Life Sciences” special edition, which recognizes industry leaders in the life sciences and highlights their careers and accomplishments.

The accompanying profile highlights Dan’s work with venture capital firms in transactions totaling over $2.5 billion, biotech company Arcellx from its formation to its IPO to follow-on public offerings and complex strategic collaboration transactions, and LENZ Therapeutics in a $83.5 million financing and dual-process IPO and merger with Graphite Bio to become a Nasdaq-listed company with over $200 million in financing proceeds.

Click here to view Dan’s full profile and to view the complete list of honorees.